FWBIFirst Wave BioPharma, Inc.

Nasdaq firstwavebio.com


$ 2.77 $ 0.01 (0.37 %)    

Friday, 26-Apr-2024 15:49:39 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 2.74
$ 2.77
$ 0.00 x 0
$ 0.00 x 0
$ 2.77 - $ 2.77
$ 2.42 - $ 65.00
45,316
na
5.55M
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-20-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-23-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-24-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-30-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
21 04-01-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-13-2018 06-30-2018 10-Q
24 05-14-2018 03-31-2018 10-Q
25 03-16-2018 12-31-2017 10-K
26 11-13-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-25-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reinstates-neutral-on-first-wave-biopharma

HC Wainwright & Co. analyst Yi Chen reinstates First Wave BioPharma (NASDAQ:FWBI) with a Neutral.

 roth-mkm-maintains-buy-on-first-wave-biopharma-lowers-price-target-to-36

Roth MKM analyst Jonathan Aschoff maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy and lowers the price target from $...

 why-limbach-holdings-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarte...

 first-wave-biopharma-completes-merger-deal-with-immunogenx-adding-phase-3-ready-candidate-for-celiac-disease

First Wave BioPharma acquires ImmunogenX, focusing on advancing GI pipeline. James Sapirstein remains Chairman & CEO, with ...

 first-wave-biopharma-inc-to-raise-4m-of-gross-proceeds-in-registered-direct-offering-of-525625-shares-of-common-stock-at-a-price-of-761-per-share

First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharm...

 why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

 why-resources-connection-shares-are-trading-higher-by-over-6-here-are-20-stocks-moving-premarket

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results f...

 whats-going-on-with-first-wave-biopharma-stock

First Wave BioPharma, Inc. (NASDAQ: FWBI) shares are trading higher Wednesday.  What To Know:

 roth-mkm-maintains-buy-on-first-wave-biopharma-adjusts-price-target-to-40

Roth MKM analyst Jonathan Aschoff maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy, adjusts target to $40 from $11.

 why-sofi-technologies-shares-are-trading-lower-by-around-13-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods dow...

 why-trinity-place-holdings-shares-are-trading-higher-by-80-here-are-20-stocks-moving-premarket

Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mor...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION